Recent research showed that GLP-1R has the promising ability to generate neuroprotection against neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and ischaemic stroke18, 19. Here, GLP1R is linked to nervous system disorder.